AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2021
Sep 7, 2021
3174_iss_2021-09-07_19f7e06c-9963-4510-8503-e7f218847492.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension
Instrument
| Instrument | Aktier | |
|---|---|---|
| Before the transaction | ||
| Shares | Data not given* | |
| Voting rights | Data not given* | |
| Transaction | ||
| Date | 06/09/2021 | |
| Limit for number of shares 10 % | ||
| Limit for number of votes | 10 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 4,595,684 |
Directly held voting rights 0 Indirectly held voting rights 4,595,684
Percentage Directly held shares 10.1 % Directly held voting rights 0 % Indirectly held voting rights 10.1 %
Resulting distribution of total
| holdings | ||
|---|---|---|
| Percentage of voting rights: |
Number of underlying shares: |
|
| Shares | 10.1 % | 4,595,684 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 10.1 % | 4,595,684 |
Group total holdings
Voting rights 4,595,684 Percentage of voting rights 10.1
Notes (other relevant informations according to law)
Aktierna innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt har förvärvat de aktuella aktierna.
Published
07/09/2021 14:45
Contact
Name Jonas Lexmark Phone 08-40942107 Email [email protected]
*Source of information has chosen not to submit the data
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13